Cargando…
Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma
The management and screening of prostate cancer (PC) is still the main problem in clinical practice. In this study, we investigated the role of aggressiveness genetic markers for PC stratification. We analyzed 201 plasma samples from PC patients and controls by digital PCR. For selection and validat...
Autores principales: | Alvarez-Cubero, Maria Jesus, Arance, Elena, de Santiago, Esperanza, Sanchez, Pilar, Sepúlveda, Maria Rosario, Marrero, Raquel, Lorente, Jose Antonio, Gonzalez-Cabezuelo, Jose Maria, Cuenca-Lopez, Sergio, Cozar, Jose Manuel, Vazquez-Alonso, Fernando, Martinez-Gonzalez, Luis Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820153/ https://www.ncbi.nlm.nih.gov/pubmed/36613987 http://dx.doi.org/10.3390/ijms24010547 |
Ejemplares similares
-
The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients
por: Alvarez-Cubero, Maria Jesus, et al.
Publicado: (2013) -
Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
por: Martínez-González, Luis Javier, et al.
Publicado: (2021) -
Mitochondrial Haplogroups and Polymorphisms Reveal No Association with Sporadic Prostate Cancer in a Southern European Population
por: Álvarez-Cubero, María Jesús, et al.
Publicado: (2012) -
Prognostic role of genetic biomarkers in clinical progression of prostate cancer
por: Alvarez-Cubero, Maria Jesus, et al.
Publicado: (2015) -
Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness
por: Robles-Fernandez, Inmaculada, et al.
Publicado: (2017)